Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

05 oct. 2023 09h00 HE | Source: Exbaq LLC

Study Published in Science Translational Medicine Shows Exbaq’s Experimental Vaccine Protects Against Many of the Most Dangerous Antibiotic Resistant Superbugs Causing Hospital Acquired Infections

Vaccine Stimulates the Body’s Macrophages, Engulfing and Killing Gram Positive/Negative Bacteria, and FungiVaccine provides protection against infections within 24hours and protection lasts for up to...
06 juil. 2022 14h00 HE | Source: Tenaya Therapeutics, Inc.

Tenaya Therapeutics Publishes Preclinical Data in Science Translational Medicine Detailing Discovery of HDAC6 Inhibitor for Treatment of Heart Failure

Tenaya’s Precision Medicine Platform Used to Identify HDAC6 Target Using Phenotypic Screening and Machine Learning Algorithms Tenaya’s HDAC6 Inhibitor TN-301 Advancing to the Clinic for HFpEF, with...
08 août 2014 13h17 HE | Source: North Shore Long Island Jewish Health System

Hofstra North Shore-LIJ School of Medicine Professor Publishes Pivotal MS Study

HEMPSTEAD, N.Y., Aug. 8, 2014 (GLOBE NEWSWIRE) -- A Hofstra North Shore-LIJ School of Medicine professor has published breakthrough research that pinpoints the origin of the cell that is alleged to...